Truewind | $13,000,000 | (Jan 17, 2025)
Conceivable Life Sciences | $18,000,000 | (Jan 16, 2025)
Hinge Bio | $30,000,000 | (Jan 16, 2025)
Certified by Founder
Lodge
RheumaGen
start up
United States
- Denver, Colorado
- 10/01/2025
- Series A
- $15,000,000
RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado. For more information, please visit rheumagen.com.
- Industry Biotechnology Research
- Website https://www.rheumagen.com/
- LinkedIn https://www.linkedin.com/company/rheumagen/
Shippeo | $30,000,000 | (Jan 16, 2025)
BeZero Carbon | $32,000,000 | (Jan 16, 2025)
Reown (prev. WalletConnect Inc.) | $13,000,000 | (Jan 16, 2025)
Lyteflo | $3,000,000 | (Jan 16, 2025)
Maki People | $28,600,000 | (Jan 16, 2025)
Alleviant Medical | $90,000,000 | (Jan 16, 2025)
Rockfish Data | $4,000,000 | (Jan 16, 2025)
The Snow League | $15,000,000 | (Jan 15, 2025)
Enhanced Medical Nutrition | $5,000,000 | (Jan 15, 2025)